The Effect of Twice Daily Aclidinium Bromide/Formoterol Fumarate 340/12 mcg vs. Once Daily Tiotropium 'Respimat' 5mcg on Static and Dynamic Hyperinflation in Patients With COPD During 24 Hours
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2018
At a glance
- Drugs Aclidinium bromide/formoterol (Primary) ; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms BOTH
- 20 Feb 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Nov 2018.
- 20 Feb 2018 Status changed from not yet recruiting to recruiting.
- 05 Jun 2017 New trial record